Literature DB >> 28470457

Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.

Jie Yuan1,2, Yi Yang1,2, Zicong Gao1,2, Zhiyong Wang1,2, Wei Ji1,2, Weijie Song1,2, Fei Zhang3,4, Ruifang Niu5,6.   

Abstract

PURPOSE: Overexpression of Annexin A2 (Anxa2) is positively correlated with breast cancer progression, drug resistance, and poor prognosis of patients with breast cancer. Tyr23 Phosphorylation by Src-family tyrosine kinase is an important post-translational modification of Anxa2. This modification regulates the subcellular localization and functions of Anxa2 and has significant effects on cell proliferation, migration, and invasion. This study aims at revealing the association of Anxa2-Tyr23 phosphorylation in Anxa2-mediated acceleration of breast cancer progression and their elaborate molecular mechanisms.
METHODS: Cell biological function experiments were performed to determine the effects of Anxa2-Tyr23 Phosphorylation on breast cancer cell proliferation and invasion in vitro and metastasis in vivo. The interaction of Tyr23 phosphorylated Anxa2 and STAT3 was verified by co-immunoprecipitation assay. Related mRNA and protein expression levels of cyclin D1 and MMP2/9 and phosphorylation level of STAT3 were detected.
RESULTS: Anxa2-Tyr23 phosphorylation is necessary for proliferation, invasion, and metastasis of breast cancer cells in vitro and in vivo. Tyr23 phosphorylated Anxa2 binds and enhances the sensitivity of STAT3 activation in response to IL-6, thereby increasing the protein and mRNA expression levels of cyclin D1 and MMP2/9 which are STAT3 key target genes and serve pivotal regulatory functions in cell proliferation and invasion, respectively.
CONCLUSION: Our findings further confirmed the regulatory role of Anxa2 and revealed the direct relationship between Anxa2-Tyr23 phosphorylation and activation of STAT3. Moreover, this study provides novel insights into the function of Anxa2-Tyr23 phosphorylation in signal transduction for further understanding of the mechanism through which Anxa2 promotes the progression of breast cancer.

Entities:  

Keywords:  Anxa2-Tyr23 phosphorylation; Breast cancer; Invasion; Proliferation; STAT3

Mesh:

Substances:

Year:  2017        PMID: 28470457     DOI: 10.1007/s10549-017-4271-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  TRG16, targeted by miR-765, inhibits breast cancer stem cell-like properties via regulating the NF-κB pathway.

Authors:  Feng Chi; Xiaoming Jin; Long Chen; Guijin He; Sijia Han
Journal:  Mol Cell Biochem       Date:  2022-06-01       Impact factor: 3.396

2.  Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma.

Authors:  Mohd Altaf Najar; Mohammad Arefian; David Sidransky; Harsha Gowda; T S Keshava Prasad; Prashant Kumar Modi; Aditi Chatterjee
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

3.  GNAQ T96S mutation abrogates the ability of wild-type GNAQ to induce apoptosis by phosphorylating annexin A2 in natural killer/T cell lymphoma.

Authors:  Wugan Zhao; Min Zhang; Guannan Wang; Enjie Liu; Guozhong Jiang; Yanping Zhang; Dandan Zhang; Xiangyu Jian; Haiyu Zhao; Chongli Zhang; Wencai Li
Journal:  Cancer Sci       Date:  2022-05-13       Impact factor: 6.518

4.  Annexin A2 overexpression associates with colorectal cancer invasiveness and TGF-ß induced epithelial mesenchymal transition via Src/ANXA2/STAT3.

Authors:  Murilo R Rocha; Pedro Barcellos-de-Souza; Annie Cristhine M Sousa-Squiavinato; Priscila V Fernandes; Ivanir M de Oliveira; Mariana Boroni; Jose A Morgado-Diaz
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

5.  Expression of Annexin A2 Promotes Cancer Progression in Estrogen Receptor Negative Breast Cancers.

Authors:  Amira F Mahdi; Beatrice Malacrida; Joanne Nolan; Mary E McCumiskey; Anne B Merrigan; Ashish Lal; Shona Tormey; Aoife J Lowery; Kieran McGourty; Patrick A Kiely
Journal:  Cells       Date:  2020-06-30       Impact factor: 6.600

6.  A Kelch domain-containing KLHDC7B and a long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer cell proliferation via the interferon signaling pathway.

Authors:  Gookjoo Jeong; Hansol Bae; Dawoon Jeong; Juyeon Ham; Sungbin Park; Hyeon Woo Kim; Han-Sung Kang; Sun Jung Kim
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

7.  Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.

Authors:  Yanling Fan; Weiyao Si; Wei Ji; Zhiyong Wang; Zicong Gao; Ran Tian; Weijie Song; He Zhang; Ruifang Niu; Fei Zhang
Journal:  Breast Cancer Res       Date:  2019-05-22       Impact factor: 6.466

8.  Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma.

Authors:  Yun Lou; Yue Yu; Xiaolia Xu; Shu Zhou; Haiyuan Shen; Tianlong Fan; Di Wu; Jie Yin; Guoqiang Li
Journal:  J Cell Mol Med       Date:  2018-12-26       Impact factor: 5.310

9.  ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.

Authors:  Sai Ma; Chen-Chen Lu; Li-Yan Yang; Juan-Juan Wang; Bo-Shi Wang; Hong-Qing Cai; Jia-Jie Hao; Xin Xu; Yan Cai; Yu Zhang; Ming-Rong Wang
Journal:  J Exp Clin Cancer Res       Date:  2018-08-06

Review 10.  A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment.

Authors:  Rose Kadye; Mihlali Stoffels; Sidne Fanucci; Siso Mbanxa; Earl Prinsloo
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.